ARCHIVES

Pertuzumab Delays Progression In HER2-Positive Breast Cancer

This article is from The Cancer Letter archive.

Vol. 34 No. 8 | August 26, 2011

Download PDF Visit The Full Archive

Related Articles

Groups Push for CMS Coverage for LDCT Lung Screening

October 3, 2014

Cancer Advocacy: Deal Returns $3M to Office of Women’s Health, Spends $3.5M On Workshops

August 1, 1997

NCCS Networker Volume 3 Issue 3, Summer 1989

June 13, 1989

DCBD Board Approves Concept for Astrocytoma Molecular Probes

July 22, 1988

The Cancer Letter Obtains “Confidential” Documents From Duke IRB Investigation

May 14, 2010

NCI Advisors Reject $30-Million Cohort Study, Approve Renewal of Phase I Clinical Trials Initiatives and American College of Radiology Imaging Network.

July 7, 2006